MBS 303 - AdisInsht - Springer
mbs303MBS 303 is a bispecific antibody targeting CD3CD20 being developed by Beijing Mabworks Biotech for the treatment of B cell non-Hodgkin lymphoma. TheMBS303 OFFICIAL|TEBAK ANGKA 2D 3D
IDR 10.000
IDR 100.000
Disc -90%